Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases

BACKGROUND: Graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) for brain metastases is a powerful prognostic tool. However, it has not been validated for non-small-cell lung cancer (NSCLC) patients with synchronous or metachronous brain metastases. METHODS: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kaiyan, Zhang, Fanrong, Fan, Yun, Cheng, Guoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481286/
https://www.ncbi.nlm.nih.gov/pubmed/32943887
http://dx.doi.org/10.2147/OTT.S255478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481286/
https://www.ncbi.nlm.nih.gov/pubmed/32943887
http://dx.doi.org/10.2147/OTT.S255478

Ejemplares similares